Drugs and Devices

FDA approves extended depth-of-focus IOL

On July 15, the Food and Drug Administration (FDA) approved Tecnis Symfony intraocular lens (IOL), the first IOL that provides cataract patients with an extended depth-of-focus, which helps improve their visual acuity at near, intermediate, and far distances. Read more

Related Articles:

Leave a Reply

You have to agree to the comment policy.